PR | 7 |
ИКС | n/a |
Страниц в Google | 970 |
Страниц в Яндексе | 0 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 16957775 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Novartis
n/a
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
UTF-8
69.04 КБ
537
4 323 симв.
3 698 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
4 | 9 |
0 | 5 | ![]() | |
![]() ![]() |
3 | 7 |
100 | 66520 | ![]() | |
![]() |
3 | 6 |
10 | 1104532 | ![]() | |
![]() |
3 | 6 |
0 | 106975 | ![]() | |
![]() ![]() |
3 | 8 |
0 | 563 | ![]() | |
![]() ![]() |
3 | 7 |
40 | 181564 | ![]() | |
![]() ![]() |
2 | 8 |
0 | 531614 | ![]() | |
![]() ![]() |
2 | 8 |
0 | 654 | ![]() | |
![]() ![]() |
2 | 8 |
0 | 113 | ![]() | |
![]() ![]() |
2 | 9 |
0 | 25 | ![]() | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Данные linkpad ( 23 Апреля 2015 ) | |
Количество ссылок на сайт | 5193 |
Количество доменов, которые ссылаются на сайт | 64 |
Количество найденных анкоров | 8 |
Исходящие (внешние) ссылки домена | 6391 |
Количество доменов, на которые ссылается сайт | 111 |
Количество исходящих анкоров | 167 |
Внешние ссылки главной страницы ( 19 ) | |
sandoz.com | Sandoz |
youtube.com/watch?v=0xZyM-DyYGA | Watch on YouTube |
novartis.com/stories/patient-perspectives/lessons-from-blind... | Learn More |
iapb.org/ | Visit the IAPB website |
novartis.com/our-focus/ophthalmology | Learn more about ophthalmology at Novartis |
novartis.com/news/novartis-and-microsoft-announce-collaborat... | Read More |
twitter.com/Novartis | @Novartis |
twitter.com/Novartis/status/1182231091761074178 | 19 hours 43 min ago On this #WorldSightDay, envision a future where we can all see the world through the wonder of our eyes. htt... |
twitter.com/Novartis/status/1181227962848428032 | 3 days 14 hours ago RT @Novartis_NSB: An incredible honor for us @Novartis to be recognized by @schwabfound and @WEF as the Schw... |
twitter.com/Novartis/status/1180123808449073154 | 6 days 15 hours ago Can you read this tweet without glasses? 1 billion others can’t either. We support @IAPB1 this #WorldSightDa... |
twitter.com/novartis | Follow Us |
novartis.com/news/news-archive?type=press_release | Media releases |
youtube.com/watch?v=dVthVEjCdLM | Opens a Dialog |
novartis.com/stories/discovery/word-street-what-cell-and-gen... | Learn More |
twitter.com/novartis | |
linkedin.com/company/novartis | |
youtube.com/user/Novartis | youtube |
facebook.com/novartis | |
instagram.com/novartis/ | |
Внутренние ссылки главной страницы ( 64 ) | |
/ | Academic Programs |
/our-focus/patients-caregivers | Patients & Caregivers |
/our-focus/healthcare-professionals | Healthcare Professionals |
/news | Media |
/investors | Investors |
/careers | Careers |
/novartis-site-directory | Novartis site directory |
/our-company | Our Company |
/our-company/board-directors | Board of Directors |
/our-company/executive-committee | Executive Committee of Novartis |
/our-company/our-strategy | Strategy |
/our-company/corporate-responsibility | Corporate Responsibility |
/our-company/diversity-inclusion | Diversity & Inclusion |
/our-company/our-culture-and-values | Culture and Values |
/our-company/global-product-portfolio | Global Product Portfolio |
/our-company/novartis-pharmaceuticals | Novartis Pharmaceuticals |
/our-company/novartis-oncology | Novartis Oncology |
/news/news-archive | News Archive |
/news/media-library | Multimedia Resources |
/news/stay-date | Subscribe to Updates |
/investors/event-calendar | Event Calendar |
/investors/financial-data | Financial Data |
/investors/share-data-analysis | Share Data & Analysis |
/investors/shareholder-information | Shareholder Information |
/our-focus | Our Focus |
/our-focus/cancer | Cancer |
/our-focus/cardiovascular-renal-and-metabolism | Cardiovascular, Renal & Metabolism |
/our-focus/immunology-dermatology | Immunology & Dermatology |
/our-focus/ophthalmology | Ophthalmology |
/our-focus/neuroscience | Neuroscience |
/our-focus/respiratory | Respiratory |
/our-focus/data-and-digital/artificial-intelligence | Artificial Intelligence |
/our-focus/cell-and-gene-therapy | Cell & Gene Therapy |
/stories/discovery | Discovery |
/stories/from-our-labs | From Our Labs |
/stories/access-to-healthcare | Access to Healthcare |
/stories/patient-perspectives | Patient Perspectives |
/stories/people-and-culture | People and Culture |
/our-science | Our Science |
/our-science/novartis-institutes-biomedical-research | Novartis Institutes for BioMedical Research |
/our-science/research-disease-areas | Research Disease Areas |
/our-science/postdoc-program | Postdoc Program |
/our-science/open-source-science | Open Source Science |
/our-science/novartis-global-pipeline | Global Clinical Pipeline |
/our-science/translational-medicine | Translational Medicine |
/our-science/novartis-clinical-trials | Novartis Clinical Trials |
/careers/career-search | Career Search |
/careers/digitalcareers | Careers in Digital |
/careers/careers-research | Careers in Research |
/careers/students-scholars | Students and Scholars |
/careers/novartis-quantitative-sciences-hackathon | Novartis Quantitative Sciences Hackathon |
/news/media-releases/novartis-data-show-cosentyx-treatment-r... | Oct 10, 2019 Novartis data show Cosentyx® treatment results in rapid and sustained resolution of signs and symptoms of psoriatic... |
/news/media-releases/novartis-real-world-evidence-confirms-h... | Oct 09, 2019 Novartis real-world evidence confirms high efficacy, long-term response and favorable safety profile of Cosentyx® i... |
/news/media-releases/novartis-data-show-more-patients-are-co... | Oct 08, 2019 Novartis data show more patients are completely symptom-free from chronic spontaneous urticaria with ligelizumab (Q... |
/news/media-releases/novartis-receives-fda-approval-beovu-of... | Oct 08, 2019 Novartis receives FDA approval for Beovu®, offering wet AMD patients vision gains and greater fluid reductions vs a... |
/our-company/contact-us | Contact Us |
/our-company/contact-us/office-locations | Office Locations |
/our-company/contact-us/investor-contacts | For Investors |
/our-company/contact-us/media-contacts | For Media |
/stories | Our Stories |
/node/121 | Novartis Site Directory |
/terms-use | Terms of Use |
/privacy-policy | Privacy Policy |
/sitemap.xml | Site Map |
США - 216.52.242.86
LinkedIn Corporation
Internap Network Services Corporation
HTTP/1.1 200 OK
Date: Fri, 11 Oct 2019 07:03:10 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
Set-Cookie: __cfduid=db922bef35992693430c26efe07844d921570777390; expires=Sat, 10-Oct-20 07:03:10 GMT; path=/; domain=.novartis.com; HttpOnly; Secure
X-Drupal-Cache: MISS
X-Content-Type-Options: nosniff
X-XSS-Protection: 1; mode=block
X-Frame-Options: SAMEORIGIN
Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Language: en
X-UA-Compatible: IE=edge,chrome=1
Link: ; rel="canonical",; rel="shortlink"
Cache-Control: public, max-age=86400
Last-Modified: Fri, 11 Oct 2019 05:30:28 GMT
Expires: Sat, 12 Oct 2019 07:03:10 GMT
Vary: Cookie,Accept-Encoding
X-Request-ID: v-3bff29b8-ebe8-11e9-9031-0b79fc4abf8b
X-AH-Environment: prod
Age: 0
Via: varnish
X-Cache: HIT
X-Cache-Hits: 25
CF-Cache-Status: HIT
Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
Server: cloudflare
CF-RAY: 523ef904fbb49f27-IAD
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"